People: Sequenom Inc (SQNM.O)
SQNM.O on Nasdaq
4.10USD
17 May 2013
4.10USD
17 May 2013
Price Change (% chg)
$-0.01 (-0.24%)
$-0.01 (-0.24%)
Prev Close
$4.11
$4.11
Open
$4.15
$4.15
Day's High
$4.25
$4.25
Day's Low
$3.97
$3.97
Volume
3,002,232
3,002,232
Avg. Vol
2,798,612
2,798,612
52-wk High
$5.36
$5.36
52-wk Low
$2.65
$2.65
Weiner, Robin
Brief Biography
Ms. Robin G. Weiner, MBA., serves as Senior Vice President - Quality and Regulatory Affairs of Sequenom Inc. Prior to joining the company, Ms. Weiner was an independent regulatory consultant to biotechnology companies, focusing on regulatory strategy, product submissions and quality management systems. From 2004 to 2007, Ms. Weiner served as vice president regulatory and government affairs at Biosite Incorporated, a medical device company, and was responsible for Biosite’s worldwide product approvals and regulatory compliance activities. Ms. Weiner holds a bachelor’s degree from the University of California, San Diego and a master’s degree in business administration from National University.
Basic Compensation
| Total Annual Compensation, | Long-Term Incentive Plans, | All Other, | Fiscal Year Total, |
|---|---|---|---|
| -- | -- | -- | -- |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
Harry Hixson |
3,154,160 |
William Welch |
1,788,550 |
Paul Maier |
849,806 |
Dirk van den Boom |
741,232 |
Ronald Lindsay |
895,403 |
Bill Bowen |
-- |
As Of 30 Dec 2011

